|
Dolutegravir + Doravirine Nuke Sparing for PWH with Severe Kidney Disease, PK, Drug Levels
|
|
|
Download the PDF
Download the PDF
Download the PDF
Efficacy and safety of dolutegravir and doravirine dual therapy
in the context of antiretroviral therapy switch:
48 weeks analysis
![1009231](../images/100923/100923-3/1009231.gif)
The DoDo experience: an alternative antiretroviral 2-drug regimen of doravirine and dolutegravir
![1009232](../images/100923/100923-3/1009232.gif)
A 2-Way Steady State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir
https://www.natap.org/2015/Pharm/Pharm_40.htm
![1009233](../images/100923/100923-3/1009233.gif)
published - A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir
![1009234](../images/100923/100923-3/1009234.gif)
![1009235](../images/100923/100923-3/1009235.gif)
![1009236](../images/100923/100923-3/1009236.gif)
|
|
|
|
|
|
|